Cargando…

Super-enhancers and novel therapeutic targets in colorectal cancer

Transcription factors, cofactors, chromatin regulators, and transcription apparatuses interact with transcriptional regulatory elements, including promoters, enhancers, and super-enhancers (SEs), to coordinately regulate the transcription of target genes and thereby control cell behaviors. Among the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qian, Guo, Lijuan, Lou, Zhiyuan, Xiang, Xueping, Shao, Jimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917125/ https://www.ncbi.nlm.nih.gov/pubmed/35277481 http://dx.doi.org/10.1038/s41419-022-04673-4

Ejemplares similares

Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets
por: Chen, Xuanrong, et al.
Publicado: (2020)

The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors
por: Li, Xiang-Ping, et al.
Publicado: (2023)

Super-enhancers: critical roles and therapeutic targets in hematologic malignancies
por: Jia, Yunlu, et al.
Publicado: (2019)

Targeting Super-Enhancers as a Therapeutic Strategy for Cancer Treatment
por: He, Yi, et al.
Publicado: (2019)

A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer
por: Liu, Qian, et al.
Publicado: (2021)

Super enhancers: Pathogenic roles and potential therapeutic targets for acute myeloid leukemia (AML)
por: Cao, Ziyang, et al.
Publicado: (2022)

Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target
por: Shao, Yingkuan, et al.
Publicado: (2021)

Super-enhancers complexes zoom in transcription in cancer
por: Wang, MengTing, et al.
Publicado: (2023)

Targeting complexes of super-enhancers is a promising strategy for cancer therapy
por: Zheng, Chuqian, et al.
Publicado: (2020)

Myosin Motors: Novel Regulators and Therapeutic Targets in Colorectal Cancer
por: Naydenov, Nayden G., et al.
Publicado: (2021)

Typical Enhancers, Super-Enhancers, and Cancers
por: Koutsi, Marianna A., et al.
Publicado: (2022)

Super-enhancer function and its application in cancer targeted therapy
por: Tang, Faqing, et al.
Publicado: (2020)

Copy Number Alterations as Novel Biomarkers and Therapeutic Targets in Colorectal Cancer
por: Tan, Elaine S., et al.
Publicado: (2022)

Super-enhancers: novel target for pancreatic ductal adenocarcinoma
por: Ghosh, Chandrayee, et al.
Publicado: (2019)

Therapeutic Targets of KRAS in Colorectal Cancer
por: Rahman, Shafia, et al.
Publicado: (2021)

Titin as a potential novel therapeutic target in colorectal cancer
por: Wei, Hongyun, et al.
Publicado: (2023)

Therapeutic Targets and Tumor Microenvironment in Colorectal Cancer
por: Gallo, Gaetano, et al.
Publicado: (2021)

Differentially Methylated Super-Enhancers Regulate Target Gene Expression in Human Cancer
por: Flam, Emily L., et al.
Publicado: (2019)

Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer
por: Catalano, Fabio, et al.
Publicado: (2022)

Etiology of super-enhancer reprogramming and activation in cancer
por: Zhou, Royce W., et al.
Publicado: (2023)

Fascin actin-bundling protein 1 in human cancer: promising biomarker or therapeutic target?
por: Liu, Hongliang, et al.
Publicado: (2021)

JMJD5 inhibits lung cancer progression by facilitating EGFR proteasomal degradation
por: Shen, Jing, et al.
Publicado: (2023)

Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma
por: Li, Meng, et al.
Publicado: (2022)

Wnt signaling in colorectal cancer: pathogenic role and therapeutic target
por: Zhao, Hui, et al.
Publicado: (2022)

Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer
por: Dmello, Rhynelle S., et al.
Publicado: (2021)

Identification of therapeutic targets of the hijacked super-enhancer complex in EVI1-rearranged leukemia
por: Kiehlmeier, Sandra, et al.
Publicado: (2021)

Super Enhancers in Cancers, Complex Disease, and Developmental Disorders
por: Niederriter, Adrienne R., et al.
Publicado: (2015)

Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies
por: Shi, Yang, et al.
Publicado: (2022)

Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance
por: Li, Guo-Hua, et al.
Publicado: (2021)

Advances in the proteomic discovery of novel therapeutic targets in cancer
por: Guo, Shanchun, et al.
Publicado: (2013)

Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies
por: Wang, Nannan, et al.
Publicado: (2022)

The molecular understanding of super-enhancer dysregulation in cancer
por: Yoshino, Seiko, et al.
Publicado: (2022)

Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer
por: Guo, Yu, et al.
Publicado: (2022)

Targeting super enhancers for liver disease: a review
por: Yang, Zhongyuan, et al.
Publicado: (2023)

Targeting Super-Enhancers for Disease Treatment and Diagnosis
por: Shin, Ha Youn
Publicado: (2018)

Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer
por: Hoskin, Ashley J., et al.
Publicado: (2023)

Super-Enhancers Dysregulations in Hematological Malignancies
por: Belloucif, Yannis, et al.
Publicado: (2022)

Delta-5-desaturase: A novel therapeutic target for cancer management
por: Pang, Lizhi, et al.
Publicado: (2021)

Mitophagy, a potential therapeutic target for stroke
por: Guan, Ruiqiao, et al.
Publicado: (2018)

Harnessing Omics Approaches on Advanced Preclinical Models to Discovery Novel Therapeutic Targets for the Treatment of Metastatic Colorectal Cancer
por: Porru, Manuela, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iugjhhntebrturnb6qbahp8lse